Acute Respiratory Tract Infections and Severe Disease Among Hospitalized Children - Scorecard - MDSpire

Acute Respiratory Tract Infections and Severe Disease Among Hospitalized Children

  • By

  • Haifa Mtaweh

  • Caitlyn L. Kaziev

  • Carlee A. Feinstein

  • Claire Seaton

  • Daniel S. Farrar

  • Rohini R. Datta

  • Sanjay Mahant

  • Aaron Campigotto

  • Gabrielle Freire

  • Rae S. M. Yeung

  • Jeffrey N. Bone

  • Francine Buchanan

  • Shaun K. Morris

  • Peter J. Gill

  • READAPT-Kids Study Group

  • Mei Han

  • Nicholas Barrowman

  • Gabriele Zitikyte

  • Cornelia Borkhoff

  • Patricia Parkin

  • Anya Nair

  • Nafisa Anwar

  • Rizk ElMadbak

  • Haniyyah Mahmood

  • Kody Wolfstadt

  • Nilushi de Silva

  • Polina Kyrychenko

  • Nardin Kirolos

  • Jonathan Fortini

  • Shamama Raza

  • Vincent Flores

  • Keane Fuerte

  • Pardis Noormohammadpour

  • Bayley Levy

  • Hafsa Azher

  • Fiona Muttalib

  • Tom McLaughlin

  • Matt Carwana

  • Srinivas Murthy

  • Manish Sadarangani

  • Connie Yang

  • Jocelyn A. Srigley

  • Jenny Retallack

  • Dave Goldfarb

  • Jonathan H. Rayment

  • Candice Wiedman

  • Melissa Braschel

  • Alam Lakhani

  • Opninder Lindstrom

  • Sanja Hadzi-Nikolova

  • Min-Jung Kim

  • Victoria Tapics

  • Henry Okpaladigbo

  • Joanna Xu

  • Zainab Zeyan

  • Baneesh Khosa

  • Gordon Krahn

  • Trish Page

  • Rita Janke

  • June 9, 2026

  • 0 min

Share

Clinical Scorecard: Severe Illness in Hospitalized Pediatric Patients Due to Acute Respiratory Tract Infections

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationChildren aged 0 to 18 years hospitalized with acute RTIs, including those with underlying conditions.
Care Setting

Key Highlights

  • RTIs are a leading cause of death in Canadian children aged 0 to 14 years, with viruses accounting for 75% of cases.
  • Common pathogens include EV-RV, RSV, influenza, and hMPV.

Guideline-Based Recommendations

Diagnosis

    Management

    • Monitor for severe illness requiring advanced respiratory support or ECMO, including specific interventions.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Management includes respiratory support, monitoring for severe complications, and specific treatment protocols.

        Clinical Best Practices

        • Conduct thorough clinical assessments including demographic data and preexisting conditions, and utilize multivariable regression for risk evaluation.

        Related Resources & Content

        Original Source(s)

        Acute Respiratory Tract Infections and Severe Disease Among Hospitalized Children

        • by Haifa Mtaweh, Caitlyn L. Kaziev, Carlee A. Feinstein, Claire Seaton, Daniel S. Farrar, Rohini R. Datta, Sanjay Mahant, Aaron Campigotto, Gabrielle Freire, Rae S. M. Yeung, Jeffrey N. Bone, Francine Buchanan, Shaun K. Morris, Peter J. Gill, READAPT-Kids Study Group, Mei Han, Nicholas Barrowman, Gabriele Zitikyte, Cornelia Borkhoff, Patricia Parkin, Anya Nair, Nafisa Anwar, Rizk ElMadbak, Haniyyah Mahmood, Kody Wolfstadt, Nilushi de Silva, Polina Kyrychenko, Nardin Kirolos, Jonathan Fortini, Shamama Raza, Vincent Flores, Keane Fuerte, Pardis Noormohammadpour, Bayley Levy, Hafsa Azher, Fiona Muttalib, Tom McLaughlin, Matt Carwana, Srinivas Murthy, Manish Sadarangani, Connie Yang, Jocelyn A. Srigley, Jenny Retallack, Dave Goldfarb, Jonathan H. Rayment, Candice Wiedman, Melissa Braschel, Alam Lakhani, Opninder Lindstrom, Sanja Hadzi-Nikolova, Min-Jung Kim, Victoria Tapics, Henry Okpaladigbo, Joanna Xu, Zainab Zeyan, Baneesh Khosa, Gordon Krahn, Trish Page, Rita Janke

        • June 9, 2026

        Related Content

        Study Reassures on Safety of Early NSAID Use

        A large cohort found no adjusted link to major congenital malformations, but questions remain for miscarriage, later pregnancy, and other outcomes.

        Adoption of a Pediatric Acute Care Cardiology Inpatient Model

        Weekly HIV Regimen Meets Phase 3 Goal

        The investigational combination pairs islatravir and lenacapavir in a once-weekly single-tablet regimen.